A coated, uncooked oat product is provided that has no added fat and comprises uncooked oat flakes having a coating adherent to the oat flakes. A coated, oat flake agglomerate is also provided, wherein each agglomerate comprises at least two uncooked oat flakes and has a fat-free coating. A flavored
A coated, uncooked oat product is provided that has no added fat and comprises uncooked oat flakes having a coating adherent to the oat flakes. A coated, oat flake agglomerate is also provided, wherein each agglomerate comprises at least two uncooked oat flakes and has a fat-free coating. A flavored, coated oat product in bulk and a flavored, coated, agglomerated oat product are provided, both of which products have flavors uniformly distributed throughout the bulk. Corn grit products are also provided and include (1) individual pieces of corn grit having a fat-free coating and (2) clusters of corn grit pieces having a fat-free coating. A method of coating uncooked oat flakes with a desired fat-free coating to form the coated, uncooked oat product is also provided. The method involves feeding uncooked oat flakes into a circulating drum, coating the oat flakes by spraying the oat flakes with a stream of coating material, drying the coated oat flakes until the oat flakes have attained the desired moisture content, and cooling the coated oat flakes. Also provided is a method of forming uncooked oat flake agglomerates having a fat-free coating. This method involves essentially the same steps as the aforedescribed method. However, in the coating step of this method, the coating material sprayed onto the oat flakes comprises a binding material that allows the oat flakes to form agglomerates of at least two oat flakes. Also provided is a method of preparing the desired coating material.
대표청구항▼
A coated, uncooked oat product is provided that has no added fat and comprises uncooked oat flakes having a coating adherent to the oat flakes. A coated, oat flake agglomerate is also provided, wherein each agglomerate comprises at least two uncooked oat flakes and has a fat-free coating. A flavored
A coated, uncooked oat product is provided that has no added fat and comprises uncooked oat flakes having a coating adherent to the oat flakes. A coated, oat flake agglomerate is also provided, wherein each agglomerate comprises at least two uncooked oat flakes and has a fat-free coating. A flavored, coated oat product in bulk and a flavored, coated, agglomerated oat product are provided, both of which products have flavors uniformly distributed throughout the bulk. Corn grit products are also provided and include (1) individual pieces of corn grit having a fat-free coating and (2) clusters of corn grit pieces having a fat-free coating. A method of coating uncooked oat flakes with a desired fat-free coating to form the coated, uncooked oat product is also provided. The method involves feeding uncooked oat flakes into a circulating drum, coating the oat flakes by spraying the oat flakes with a stream of coating material, drying the coated oat flakes until the oat flakes have attained the desired moisture content, and cooling the coated oat flakes. Also provided is a method of forming uncooked oat flake agglomerates having a fat-free coating. This method involves essentially the same steps as the aforedescribed method. However, in the coating step of this method, the coating material sprayed onto the oat flakes comprises a binding material that allows the oat flakes to form agglomerates of at least two oat flakes. Also provided is a method of preparing the desired coating material. l. vol. 116(3)579-584, 1976.* Youdim et al. Nonspecific suppression of tumor growth by an immune reaction to Listeria monocytogenes. J. Natl. Cancer Inst. vol. 52(1)193-198, 1974.* Youdim et al. Cooperation of immune lymphoid and reticuloendothelial cells during Listeria monocytogenes-mediated tumor immunity. Cancer Res. vol. 37(4)991-996, 1977.* Eisenstein et al. Immunotherapy of a plasmacytoma with attenuated salmonella. Medical Oncology. vol. 12:103-108, Jan. 1995.* Pidherney et al. In vitro and in vivo tumoricidal properties of a pathogenic/free-living amoeba. Cancer Lett. vol. 72:91-98, Jan. 1995.* Alizadeh et al. Apoptosis as a mechanism of cytolysis of tumor cells by a pathogenic free-living amoeba. Infect. Immun. vol. 62(4):1298-1303, Apr. 1994.* Sakamoto et al. Antitumor effect of mromal intestinal microflora on Ehrlich ascites tumor. Jpn. J. Cancer Res. (Gann) vol. 79:109-116, Jan. 1988.* Bast RC Jr et al., "Antitumor activity of bacterial infection. II. effect of Listeria monocytogenes on growth of a guinea pig hepatoma", J Natl Cancer Inst. Mar. 1975; 54(3):757-61. Bast RC Jr, "Antitumor activity of bacterial infection. I. Effect of Listeria monocytogenes on growth of a murine fibrosarcoma", J Natl Cancer Inst. Mar. 1975; 54(3):749-56. Hibbs et al., Role of activated macrophages in nonspecific resistance to neoplasia, J Reticuloendothel Soc. Sep. 1976; 20(3):223-31. Keller R, "Resistance to a non-immunogenic tumor, induced by Corynebacterium parvum or Listeria monocytogenes, is abrogated by anti-interferon gamma", Int J Cancer. Oct. 15, 1990; 46(4):687-90. Koshimura et al., "On the streptolysis S synthetizing and anticancer activities of cell-free extract from living hemolytic streptococci", Cncer Chemo. 13:107, Jul., 1961. Mizutani and Mitsuoka, 1980, "Inhibitory Effect of Some Intestinal Bacteria on Liver Tumorigenesis in Gnotobiotic C3H/He Male Mice," Cancer Letter 11:89-96. Murata et al., 1965, "Oncolytic Effect of Proteus Mirabilis Upon Tumor Bearing Animal," Life Science 4:1055-67. North et al., "T-cell-mediated concomitant immunity to syngeneic tumors. I. Activated macrophages as the expressors of nonspecific immunity to unrelated tumors and bacterial parasites", J Exp Med. Feb. 1, 1977; 145(2):275-92. Reilly CH, "Microbiology and cancer therapy: A Review", Cancer Res. 13(12): 821, Dec. 1953. Youdim et al., "Resistance to tumor growth mediated by Listeria monocytogenes: collaborative and suppressive macrophage-lymphocyte interactions in vitro", J Immunol. Nov. 1976; 117(5 Pt.2):1860-5. Youdim S, "Resistance to tumor growth mediated by Listeria monocytogenes. Destruction of experimental malignant melanoma by LM-activated peritoneal and lymphoid cells", J Immunol. Mar. 1976; 116(3):579-84. Youdim, S, et al., "Nonspecific suppression of tumor growth by an immune reaction to Listeria monocytogenes", J Natl Cancer Inst. Jan. 1974; 52(1):193-8. Youdim.et al., "Cooperation of immune lymphoid and reticuloendothelial cells during Listeria monocytogenes-mediated tumor immunity", Cancer Res. Apr. 1977; 37(4):991-6. Zinkernagel RM, "Early appearance of sensitized lymphocytes in mice infected with Listeria monocytogenes", J Immunol. Feb. 1974; 112(2):496-501. J. Adler, 1973, "A method of measuring chemotaxis and use of the method to determine optimum conditions for chemotaxis by Escherichia coli", J Gen Microbiol 74:77-91. Alizadeh et al., 1994, "Apoptosis as a mechanism of cytosis of tumor cells by a pathogenic free-living amoeba", Infect Immun 62:1298-1303. K. Bagshawe, 1995, "Antibody-directed enzyme prodrug therapy: A review", Drug Dev Res 34:220-230. Barry et al., 1995, "Protection against mycoplasma using expression library immunization", Nature 377:632-635. Barth and Morton, 1995, "The role of adjuvant therapy in melanoma management", Cancer 75 (Suppl.2):726-734. R. Berggren, 1995, "Recombinant salmonella as an oral HIV vaccine", NIH project No. 5 K01 AI01248-02. R. Bone, 1993, "Gram-neg
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (11)
Gajewski Robert J. (Crystal MN), Cereal presweetened with aspartame and cold water soluble gum coating and method of preparation.
Calandro Thomas P. (Paterson NJ) DeLauder W. Richard (Randolph NJ) Verrico Marsha K. (Fair Lawn NJ), Process for the production of a flavored cereal product.
Behnke Ronald J. ; Dawes Derek D. ; Godsey Gregory L. ; Hurd Ronald D. ; Roufs John G. ; Veenhuis Gary C., Topical coating applying apparatus and methods.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.